Institute of Basic Research in Clinical Medicine, Chinese Academy of Chinese Medical Sciences, Beijing 100700, China.
Chin J Integr Med. 2011 Nov;17(11):811-7. doi: 10.1007/s11655-011-0891-z. Epub 2011 Nov 6.
Chinese medicine (CM) pattern diagnosis (Bian zheng or syndrome differentiation), as another patient classification approach, has been incorporated with biomedicine diagnosis in clinical practice in China, and the clinical experience has proven that the integration of biomedicine and CM is better in the treatment of many diseases. CM pattern diagnosis is completely different from the diagnosis in biomedicine, and it must take an active role in innovation for medical sciences. This paper is trying to discuss how CM pattern diagnosis lead to innovations in basic research, clinical research and new drug discovery. Scientific basis of CM pattern in innovation of basic research, clinical efficacy and safety, CM pattern based clinical trial design, CM pattern and clinical practice guideline in innovation of clinical study, CM pattern based indication finding, and CM pattern based network pharmacology in innovation of new drug discovery have been discussed.
中医(CM)模式诊断(Bianzheng 或 syndrome differentiation),作为另一种患者分类方法,已在中国的临床实践中与生物医学诊断相结合,临床经验证明,生物医学和 CM 的结合在治疗许多疾病方面效果更好。CM 模式诊断与生物医学诊断完全不同,它必须在医学科学的创新中发挥积极作用。本文试图探讨 CM 模式诊断如何导致基础研究、临床研究和新药发现的创新。CM 模式在基础研究创新中的科学依据、临床疗效和安全性、基于 CM 模式的临床试验设计、CM 模式和临床实践指南在临床研究创新中的作用、基于 CM 模式的适应症发现,以及基于 CM 模式的网络药理学在新药发现中的创新,都进行了讨论。